Annette E. Fleckenstein

Affiliations: 
Neuroscience University of Utah, Salt Lake City, UT 
Area:
Toxicology, Pharmacology
Google:
"Annette Fleckenstein"
Mean distance: 15266.6
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Magee CP, Le BD, Siripathane YH, et al. (2021) Methcathinone decreases dopamine transporter function: Role of protein kinase C. Journal of Neurochemistry
Magee CP, German CL, Siripathane YH, et al. (2020) 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters. The Journal of Pharmacology and Experimental Therapeutics
Magee CP, Siripathane YH, Le BD, et al. (2020) Methcathinone Rapidly Decreases Dopamine Transporter Function: Role of Calcium and Protein Kinase C The Faseb Journal. 34: 1-1
Pittenger ST, Swalve N, Chou S, et al. (2016) Sex differences in neurotensin and substance P following nicotine self-administration in rats. Synapse (New York, N.Y.)
Baladi MG, Nielsen SM, McIntosh JM, et al. (2016) Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors. Behavioural Pharmacology
Fricks-Gleason AN, German CL, Hoonakker AJ, et al. (2016) An acute, epitope-specific modification in the dopamine transporter associated with methamphetamine-induced neurotoxicity. Synapse (New York, N.Y.)
Charntikov S, Swalve N, Pittenger S, et al. (2016) Corrigendum to “Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotine” [Neuropharmacology 75 (2013) 138–144] Neuropharmacology. 101: 590
German CL, Baladi MG, McFadden LM, et al. (2015) Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacological Reviews. 67: 1005-24
Vieira-Brock PL, McFadden LM, Nielsen SM, et al. (2015) Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits. The Journal of Pharmacology and Experimental Therapeutics
Vieira-Brock PL, McFadden LM, Nielsen SM, et al. (2015) Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp)
See more...